Á¦1ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
°³ÃÖ Àå¼Ò : »ñÆ÷·Î½Ã
ÁÖÃÖ : AHCC ¿¬±¸È¸
ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷ÈÇÐ
ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷ÈÇÐÀÇ Æ¯Çã°ø¹ýÀ¸·Î ź»ýÇÑ AHCCÀÇ ±â´É¼ºÀ» ¿¬±¸ÇÏ°í
±× ¼º°ú¸¦ º¸°íÇÏ´Â AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ°¡ °³ÃֵǾú½À´Ï´Ù.
AHCC ¿¬±¸È¸´Â ¸Å³â ÀϺ» »ñÆ÷·Î¿¡¼ ¿¸®¸ç ¼¼°è °¢±¹ÀÇ °ü°èÀÚµéÀÌ Âü°¡ÇÕ´Ï´Ù.
AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ´Â ¸Å³â ¿¸± °èȹÀÔ´Ï´Ù.
General Lecture
¡°Immunologic effect of AHCC and its fractions on animal model¡±
Yong-Qing Li, et al. £¨Hokkaido University, Japan£©
¡°Active ingredient of AHCC and ameliorative effect of sideeffect caused by chemotherapy¡±
Masatoshi Yamazaki, et al. £¨Teikyo University, Japan£©
¡°The interim report about AHCC active ingredient¡±
Gen-ichiro Nonaka, et al. £¨Kyusyu University, Japan£©
¡°Case reports of AHCC¡±
Akikuni Yagita, et al. £¨Kyorin University, Japan£©
¡°Analysis of quarity of life¡±
Youko Ishihara, et al. £¨Tokyo Women¡¯s Medical University, Japan£©
¡°Case reports of AHCC¡±
Yoshiki Yamada, et al. £¨Zikei Clinic, Japan£©
¡°Case report on gastrointestinal cancer at the terminal stage¡±
Yusai Kawaguchi, et al. £¨Fujimoto Hospital, Japan£©
¡°The effect of AHCC on immune function¡±
Buxiang Sun, et al. £¨The Institute of Public Health, Japan£©
¡°Clinical case report of AHCC¡±
Hiromi Kita, et al. £¨Kita Hospital, Japan£©
¡°Effect of AHCC on MRSA and hepatitis C¡±
Naomi Hazama, et al. £¨Ohita Psychiatric Hospital, Japan£©